Medical Cannabis in Canada: The Need for Insurance Coverage ExpansionCANNABIS AND CANNABINOID RESEARCHIF2.72024-02-010OAAI
Letter to the Editor: The Need for Equitable Health Care Among Medical Cannabis Patients in CanadaCANNABIS AND CANNABINOID RESEARCHIF2.72022-10-012OAAI
Comment on pediatric cannabis intoxication trends in the pre and post-legalization eraCLINICAL TOXICOLOGYIF3.32021-09-091PRE
Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in CanadaFRONTIERS IN PUBLIC HEALTHIF3.42021-05-2026OAAI
Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex DifferencesCANNABIS AND CANNABINOID RESEARCHIF2.72019-12-0140OAAI
Activation of endothelial IKCa channels underlies NO-dependent myoendothelial feedbackVASCULAR PHARMACOLOGYIF3.52015-11-0126PREAI
Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking ActionsJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82014-10-019PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向